Cardiovascular risk factors and mortality in patients with coronary heart disease

Christof Prugger1, Jürgen Wellmann, Jan Heidrich

  • 1Institute of Epidemiology and Social Medicine, University of Münster, Domagkstr. 3, 48149, Münster, Germany.

Insights

Diabetes and smoking significantly increase long-term mortality risk in coronary heart disease (CHD) patients undergoing secondary prevention. Managing these factors is crucial for improving survival in established CHD.

Area of Science:

  • Preventive Cardiology
  • Cardiovascular Disease Epidemiology
  • Clinical Outcomes Research

Background:

  • Secondary prevention aims to reduce recurrent events and prolong survival in established coronary heart disease (CHD).
  • Risk factors for long-term mortality in CHD patients require ongoing investigation within routine secondary prevention programs.

Purpose of the Study:

  • To examine risk factors for long-term mortality in patients with established CHD who entered routine secondary prevention.
  • To identify key predictors of all-cause, cardiovascular, and cerebrovascular mortality in this patient cohort.

Main Methods:

  • Analysis of data from 747 patients across EUROASPIRE I and II studies in Münster, Germany.
  • Follow-up for a mean of 8.0 years, with baseline examinations at least 6 months post-event/intervention.
  • Multivariate Cox proportional hazards models used to identify mortality predictors.

Main Results:

  • A total of 125 deaths (16.7%) occurred during follow-up.
  • Diabetes mellitus (HRR 2.24) and smoking (HRR 1.95) were significant predictors of all-cause mortality.
  • Diabetes mellitus also predicted cardiovascular (HRR 2.36) and CHD mortality (HRR 2.40).
  • Systolic blood pressure predicted cerebrovascular disease mortality (HRR 1.04 per mmHg increase).

Conclusions:

  • Long-term mortality in coronary patients receiving routine secondary prevention is substantial.
  • Diabetes mellitus and smoking are critical risk factors requiring management in established CHD.
  • Targeting diabetes and smoking cessation is essential for improving outcomes in secondary CHD prevention.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...